These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12595764)

  • 1. Expression and purification of E2/NS1 protein of hepatitis C virus and detection of anti-E2/NS1 antibodies in chronic liver disease patients.
    Pandya J; Chakraborti A; Chawla Y
    J Biomed Sci; 2003; 10(2):276-82. PubMed ID: 12595764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease.
    Yokosuka O; Omata M; Ito Y; Ohto M
    Gut; 1993; 34(2 Suppl):S64-5. PubMed ID: 7686121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Mita E; Ohkawa K; Katayama K; Fusamoto H; Kamada T
    Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, immunological characterization and application of Escherichia coli-derived hepatitis C virus E2 proteins.
    Liu J; Zhu L; Zhang X; Lu M; Kong Y; Wang Y; Li G
    Biotechnol Appl Biochem; 2001 Oct; 34(2):109-19. PubMed ID: 11592917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C.
    Kobayashi M; Tanaka E; Matsumoto A; Ichijo T; Kiyosawa K
    J Gastroenterol Hepatol; 1997 Jan; 12(1):73-6. PubMed ID: 9076628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MBP-HCV NS1/E2 fusion protein in E. coli and detection of anti-NS1/E2 antibody in type C chronic liver disease.
    Mita E; Hayashi N; Ueda K; Kasahara A; Fusamoto H; Takamizawa A; Matsubara K; Okayama H; Kamada T
    Biochem Biophys Res Commun; 1992 Mar; 183(3):925-30. PubMed ID: 1314578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of anti-E2 in the diagnosis of HCV infection in patients on maintenance hemodialysis: anti-E2 is frequently detected among anti-HCV antibody-negative patients.
    Lee DS; Lesniewski RR; Sung YC; Min WK; Park SG; Lee KH; Kim HS
    J Am Soc Nephrol; 1996 Nov; 7(11):2409-13. PubMed ID: 8959633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human hepatocyte protein(s), which binds specifically to the recombinant envelope-2/non-structural-1 protein of hepatitis C virus.
    Pandya J; Chakraborti A; Chawla Y; Dilawari JB; Sehgal S; Ganguly NK
    Virus Res; 2002 Aug; 87(2):135-143. PubMed ID: 12191777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment.
    Zampino R; Marrone A; Durante Mangoni E; Santarpia L; Sica A; Tripodi MF; Utili R; Ruggiero G; Adinolfi LE
    J Med Virol; 2004 May; 73(1):33-7. PubMed ID: 15042645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area.
    Paterlini P; Driss F; Nalpas B; Pisi E; Franco D; Berthelot P; Bréchot C
    Hepatology; 1993 Jan; 17(1):20-9. PubMed ID: 8380790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
    Rosa D; Campagnoli S; Moretto C; Guenzi E; Cousens L; Chin M; Dong C; Weiner AJ; Lau JY; Choo QL; Chien D; Pileri P; Houghton M; Abrignani S
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1759-63. PubMed ID: 8700831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
    Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
    Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection by western blotting of an antibody to the hepatitis C virus E1 envelope protein in sera of patients with chronic liver disease.
    Hada H; Koide N; Hanafusa T; Sakaguchi K; Shinji T; Sasaki S; Oka T; Takayama N; Yumoto Y; Tsuji T
    Acta Med Okayama; 1992 Oct; 46(5):365-70. PubMed ID: 1279946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis.
    Tsutsumi M; Urashima S; Takada A; Date T; Tanaka Y
    Hepatology; 1994 Feb; 19(2):265-72. PubMed ID: 7507461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum.
    Iijima A; Tanaka E; Kobayashi M; Yagi S; Mizokami M; Kiyosawa K
    J Gastroenterol Hepatol; 2000 Mar; 15(3):311-9. PubMed ID: 10764034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.